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More than 60% of the estimated 40 million persons with HIV/AIDS worldwide live in sub-Saharan Africa, where poverty, social
insecurity, food shortages and malnutrition are major problems.1 In children under the age of 5 years, who live in developing
countries, malnutrition has been associated with 50% of the 10.8 million deaths mainly caused by neonatal disorders, diarrhoea,
pneumonia, malaria and HIV/AIDS.2 Likewise micronutrient deficiencies are widespread and are associated with increased
morbidity and mortality particularly in relation to infectious diseases.3 This review focuses on the interaction between
micronutrients and HIV/AIDS and discusses recent research findings that may have important public health implications in terms
of the case management of persons with HIV/AIDS.
Micronutrients are trace elements and vitamins essential to all
micro-organisms, plants and animals. They play an important
role in gene expression, cellular differentiation and immune
function. In addition many exhibit antioxidant properties. They
are therefore essential for human health and development. 
Of all the micronutrients vitamin A and zinc deserve special
mention. Deficiencies of both are widespread in developing
countries and contribute to the morbidity and mortality from
infectious diseases. In children a pooled analysis of randomised
controlled trials of prophylactic zinc supplementation has been
associated with a 41% reduction in the incidence of pneumonia
and an 18% reduction in the incidence of diarrhoeal disease.4
Zinc was also found to have a therapeutic benefit in sick
children through promoting recovery from acute and persistent
diarrhoea, and from severe pneumonia.5 Zinc supplementation
was also associated with a two-thirds reduction in mortality in
a randomised, double-blind, controlled trial of small-for-
gestational age infants in India who were given zinc
supplementation.6 Vitamin A supplementation has resulted in a
23% reduction in all-cause mortality in children aged 6 - 60
months7 and more specifically in children with severe measles.8
The hallmark of AIDS is immune suppression resulting in acute,
recurrent and chronic opportunistic infections. While HIV is the
main cause of the immune suppression, other factors
contribute. These include concomitant malnutrition,
opportunistic infections, in particular tuberculosis, and
micronutrient deficiencies.
Micronutrient deficiencies are common in persons with HIV
infection and AIDS in both developing and developed
countries.9 They occur as a consequence of a number of factors
including reduced intake as a result of the anorexia that occurs
with AIDS and opportunistic infections, excessive losses in the
stools in patients with diarrhoea, malabsorption and parasitic
infestations.10 These deficiencies are more pronounced in
individuals with advanced disease and in situations where diets
are inadequate in meeting the recommended daily
requirements of micronutrients. Recent studies have
highlighted significant multiple micronutrient deficiencies in
South Africans. A study of stable, HIV-infected children in Cape
Town revealed that 62% had two or more trace element or
vitamin deficiencies.11 Most children were vitamin A deficient. In
addition another study reported significant vitamin A and zinc
deficiency in adults. Levels tended to be lower in individuals
with stage 3 and 4 disease and there was a positive correlation
with CD4 counts.12
Micronutrients are essential to immune function and their
deficiencies may act as co-factors in HIV disease progression.
Vitamins A, B6, B12, C and E, beta-carotene, zinc, copper,
selenium, magnesium and iron deficiencies have all been
described in association with HIV infection.13,14 In general
vitamin A deficiency has been associated with increased
morbidity and mortality and with increased transmission of HIV
from mother to child.15,16
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Selenium is an important antioxidant and deficiency has been
reported to reduce immune function in animal studies.17 Low
plasma selenium levels have been described early in the disease
process and are linked to faster disease progression and higher
morbidity in HIV-positive children.18 It is known that cardiac
muscle dysfunction in HIV-infected children is associated with
a higher mortality.19 The contribution of copper and manganese
to immune function is not clear but children with overt copper
deficiency (Menkes’ syndrome) are prone to infection.17 Copper
deficiency has been documented in adults with HIV infection.
The equilibrium in iron homeostasis is delicate – deficiency or
excess both negatively affect immune function. As in other
groups of HIV-infected subjects, anaemia is a common finding
in HIV-infected South African children20,21 and is known to
enhance disease progression and increase mortality.22
There is growing evidence to support zinc supplementation as a
possible public health intervention strategy that could enhance
the health status of HIV-infected children and undernourished
children in developing countries. Zinc is best derived from
animal rather than cereal proteins. Bioavailability is good from
breast-milk in the first 4 - 6 months of life, but this is markedly
reduced by high-phytate diets. Excessive zinc losses occur in
diarrhoeal disease leading to loss of the gastrointestinal
epithelial integrity and absorptive power.23 HIV-infected
children in Zaire were found to have an 11-fold higher risk than
uninfected controls of dying from diarrhoeal disease.24 The
other consequence of zinc deficiency is impaired
thymolymphoid integrity and reversible immune dysfunction,
particularly of T-lymphocyte cell-mediated immunity, and
hence deficiency may contribute to infectious morbidity. Zinc
deficiency appears to be relatively common in adult HIV-
infected individuals even at the asymptomatic stage but is not
well documented in children13,25 and may be more common than
is currently appreciated.
A number of studies have demonstrated the beneficial effects
of supplementation with single micronutrients. Most studies,
excluding those evaluating the role of vitamin A, have been
small ones involving less than 50 individuals.
There is no doubt that vitamin A supplementation is beneficial
in children. Vitamin A supplementation in HIV-infected children
has been shown to improve immune function,26 reduce
morbidity from diarrhoeal disease27 and reduce mortality in
HIV-infected children.28 However, a number of clinical trials in
Africa indicated that vitamin A supplementation in pregnant
women was not associated with reduced mother-to-child
transmission of HIV.29-31 
Vitamin B6 supplementation in HIV-positive adults has been
associated with improved survival.32 Supplementation with
vitamins B1 or B6 or vitamin E has been associated with reduced
progression to AIDS, and vitamin B12 supplementation has been
associated with improvement of AIDS dementia. Selenium
supplementation in a small cohort of HIV-infected adults with
low selenium levels and dilated cardiomyopathy resulted in
improved left ventricular function in 2 out of 3 patients.33 Zinc
supplementation in HIV-positive adults showed potential
benefit in reducing candida- and pneumocystis-related
infections, increasing CD4 lymphocyte counts and improving
weight gain.34
While a number of studies have shown potential benefit
following supplementation with individual micronutrients,
there have been few randomised clinical trials evaluating the
impact of multiple micronutrients in combination. 
Multivitamin supplementation in pregnant HIV-positive women
in Tanzania was shown to reduce progression of HIV to AIDS or
death from AIDS-related causes significantly by 59% over the
first 2 years and by 29% over the whole 4 - 8-year
supplementation and follow-up period. The authors of this
study suggest that multivitamins could be a low-cost means of
delaying initiation of antiretroviral therapy in HIV-infected
women.35
In a study from Zimbabwe no effect on diarrhoeal morbidity or
mortality was found from supplementing HIV-positive adults
with high doses of vitamins A, C and E, zinc and selenium for 2
weeks.36 However, the patients had advanced HIV disease with
persistent diarrhoea and may not have absorbed the
micronutrients. 
In Thailand a study of a commercial supplement containing 18
micronutrients and taken for 48 weeks was associated with a
reduction in mortality (mortality hazard ratios = 0.37 (95%
confidence interval (CI) 0.13, 1.06) particularly in those with a
CD4 count <100 x 106/l.37
While in most instances single micronutrient supplements have
been associated with benefits, a few studies have indicated
possible adverse effects in association with excessive
supplementation, particularly of vitamin A and zinc. 
A study done on HIV-infected pregnant and lactating women in
Tanzania who were randomly assigned to vitamin A or
multivitamins (excluding vitamin A) showed an increased risk of
HIV-1 vertical transmission in women receiving vitamin A
supplementation. Multivitamin supplementation, however,
significantly reduced HIV-1 transmission in immunologically
and nutritionally compromised mothers as well as child
mortality at 24 months.38 Similar studies from Malawi and
South Africa reported no such effect.20,29 Observational studies
have also suggested an increased rate of progression in
individuals consuming large amounts of vitamin A.
Experimental data also suggest that vitamin A increases viral
replication in vitro. It is reassuring to note that a number of
clinical studies have not demonstrated such an effect.
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There is also a concern that zinc may potentiate HIV replication
since the HIV-Tat protein and the HIV nucleocapsid NCp7
proteins are strongly zinc dependent.39 Evidence from one
observational study suggested that high-dose zinc
supplementation was associated with increased HIV/AIDS
disease progression and mortality in HIV-positive adults.32
Should we provide routine micronutrient supplements to
persons with HIV/ AIDS? If we do, what dose do we use and for
how long? What is the role of micronutrient supplementation
in individuals treated with antiretrovirals? These are important
questions to address given concerns that have been raised
about possible adverse events, particularly in relation to zinc.
For these reasons we have been involved in studies evaluating
the safety and efficacy of micronutrient supplementation in
HIV-positive children. The first study was designed to assess the
safety of low- and high-dose zinc supplementation in HIV-
positive children. This study also provided information that
informed our second study, which was designed to evaluate the
efficacy of zinc and a micronutrient mixture in HIV-positive
children.
SAFETY OF ZINC SUPPLEMENTATION IN HIV-
POSITIVE CHILDREN40
The objective of this study was to evaluate the safety and
tolerability of zinc supplementation in HIV-infected children.
We conducted a double-blind, randomised, placebo-controlled
clinical trial in 39 clinically stable HIV-infected children aged 6
months to 6 years attending the Infectious Diseases Clinic at
Red Cross Children’s Hospital, Cape Town. Children excluded
from the study included those who had an intercurrent
infection or an axillary temperature of > 38°C, had recently
been hospitalised, had any opportunistic infection, tuberculosis
or chronic lung disease or had received high-dose vitamin A,
trace elements or zinc supplements within the preceding 8
weeks. The patients were randomly assigned to one of three
treatment arms: placebo, a low-dose zinc sulphate supplement
(0.5 mg/kg/day elemental zinc), and a high-dose zinc
supplement (3 mg/kg/day to a maximum of 45 mg elemental
zinc). The trial drugs were given orally daily over 6 weeks and
the children were seen weekly for 12 weeks from start to end of
the study. Children were clinically evaluated at baseline and at
monthly intervals. Investigations including CD4 counts and viral
loads were done at baseline, and at 6 and 12 weeks’ follow-up.
The baseline characteristics of the three groups were similar. Of
note, the median age and CD4 counts were 30 months and 20%
respectively. Zinc supplementation was not associated with any
significant clinical adverse events and did not affect CD4
counts or viral loads. High-dose zinc supplementation in HIV-
infected children was safe and generally well tolerated. The
study concluded that clinical trials to assess the efficacy of zinc
to reduce infectious morbidity and mortality in HIV-positive
children need to be done. 
EFFICACY OF ZINC SUPPLEMENTATION COMPARED
WITH MULTIPLE MICRONUTRIENTS41
The objective of this randomised, placebo-controlled clinical
trial was to determine the efficacy of zinc and a multiple
micronutrient mixture in reducing morbidity and mortality in 
6 - 72-month-old HIV-positive children at Red Cross Hospital,
Cape Town. Children were randomised to one of three groups:
group A received multivitamins and placebo, group B received
multivitamins and trace elements, and group C received
multivitamins and zinc. Children with a history of a significant
acute illness within the last 6 weeks before the trial, who had
received high-dose vitamin A or mineral supplements within
the past 3 months or who were suspected of having
tuberculosis or another invasive opportunistic infection were
excluded from the study. 
All children received the standard multivitamin syrup
(5 ml/day): vitamin A (3 000 U), vitamin D (300 IU), vitamin C
(30 mg), vitamin B1 (1.65 mg), vitamin B2 (1.32 mg),
nicotinamide (11 mg) and vitamin B6 (1 mg). The trace element
solution contained the following (1 ml): zinc acetate 0.51 mg
(providing 506.28 µg/ml elemental zinc), copper sulphate 61 µg
(elemental copper), manganese sulphate (0.024 µg/ml
manganese), selenium selenite 8 µg/ml, magnesium chloride
71.7 µg/ml, potassium iodide 0.08 µg/ml, chromic chloride 0.70
µg/ml, citric acid, sodium citrate, raspberry flavouring, and
hydroxybenzoate. The daily dose was 1 ml/kg/day with a
maximum of 20 ml/day. The dose of zinc was 3 mg/kg/day, with
a maximum of 45 mg daily. The trial drugs were given orally
daily over 6 months and the children were seen monthly for a
year. Children were clinically evaluated at baseline and at
monthly intervals. Investigations including CD4 counts and viral
loads were done at baseline, and at 3-monthly and 6-monthly
intervals, respectively. 
The primary endpoint was the reduction in significant adverse
events including hospitalisation and death. A total of 124
children were enrolled in the study (mean age 32 months).
Baseline characteristics were similar for all children with the
exception that there were significantly more immuno-
compromised children in the group receiving zinc supplements
(group C): 43% versus 25% in the placebo group (group A).
Compared with the placebo and trace element groups (groups
A and B) the zinc-treated group reported significantly fewer
episodes of hospitalisation and diarrhoeal disease. In addition
there was a tendency towards reduced episodes of pneumonia
in the zinc-treated group. There was no difference in the groups
receiving trace elements and placebo. No significant interaction
between micronutrients and antiretrovirals were reported. In
conclusion, zinc supplementation was associated with reduced
infective episodes and hospitalisations in HIV-positive children.
In summary, micronutrients may be involved in the
pathogenesis of HIV disease. Micronutrient deficiencies are
UNANSWERED QUESTIONS?
CONCLUSION
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common in persons with HIV/AIDS, are more pronounced in
persons with severe disease, and contribute to morbidity and
mortality. Micronutrient supplementation, in particular zinc and
vitamin A, are beneficial in HIV-positive persons. A daily dose of
3 mg zinc for 6 months has been shown to be safe and
effective, and 6-monthly supplements of high-dose vitamin A
likewise (50 000 IU before 6 months; a single dose of 100 00 IU
between 6 and 11 months; and a single dose of 200 000 IU
every 6 months from 12 months onward). Multivitamins have
been found to be effective in delaying disease progression and
in reducing vertical transmission in immunologically and
nutritionally compromised HIV-infected women. However,
more work on multiple micronutrients needs to be done; in
particular, optimal formulations and dosage regimens have to
be defined. Nevertheless, in situations where micronutrient
deficiencies are endemic, these nutrients should be provided
through food fortification or micronutrient supplements,
containing at least 1 - 2 times the recommended dietary
allowance, where available. 
Nutritional interventions to improve the health and well-being
of persons living with HIV/AIDS, including micronutrient
supplementation, need to be optimised and research into
identifying optimal interventions and operational strategies is
encouraged. However, this should not be done to the detriment
of antiretroviral strategies, the one intervention to date that
has consistently been shown to be associated with a reduction
in the disease burden associated with AIDS.
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Aspen Pharmacare pledges R 75 000.00 Annual Unconditional
Educational Grant to Southern African HIV Clinicians Society
Dr. Des Martin, President of the Southern African HIV Clinicians Society gratefully received the Unconditional Education Grant
from Aspen Pharmacare.
The Grant will be administered by the President and Executive Committee of the Society. It will be used for the sponsoring
of selected members to attend local and international conferences.
Recipients of sponsorship will be selected according to:
• Doctors showing promise in fields of HIV Medicine
• Doctors currently in the HIV field in either private or public sectors
• Doctors working in urban or rural areas
• Doctors unable to attend conferences without part or full sponsorship
Further information is available from the HIV Clinicians Society.
Tel: 011 453 5066
email: sahivsoc@sahivsoc.org
Aspen Pharmacare’s Mr. Gavin Wiggill hands over a cheque
for R 75 000.00 to a delighted Dr. Des Martin
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